Picture of Dr. Agarwal's Health Care logo

AGARWALEYE — Dr. Agarwal's Health Care News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Kotak starts India's Dr Agarwal's Health Care with 'add'

** Kotak starts coverage on India's Dr Agarwal's Health Care DRAA.NS with "add" and a fair value of 425 rupees

** Brokerage says high-priced surgical cases, which comprise 62%-65% of the total cases, will boost overall revenue for the eye care services provider over FY28

** Kotak's PT represents a 7.6% upside to DRAA's current price of 394.85 rupees; however, stock down 2% on the day

** Adds, DRAA's strong EBITDA growth trajectory broadly compensates for its currently lower, albeit, improving margins

** Avg rating of three analysts, excluding Kotak, at "buy"; median PT is 502 rupees - data compiled by LSEG

** Stock down 1.7% since trading debut in February

 (Reporting by Kashish Tandon in Bengaluru)

 ((Kashish.tandon@thomsonreuters.com))

Recent news on Dr. Agarwal's Health Care

See all news